Insider Trading Activity For vTv Therapeutics Inc (NASDAQ:VTVT)
Ronald O Perelman , Major Shareholder of vTv Therapeutics Inc (NASDAQ:VTVT) reportedly Bought 815,217 shares of the company’s stock at an average price of 1.84 for a total transaction amount of $1,499,999.28 SEC Form
Insider Trading History For vTv Therapeutics Inc (NASDAQ:VTVT)
Analyst Ratings History For vTv Therapeutics Inc (NASDAQ:VTVT)
- On 8/4/2017 HC Wainwright Set Price Target of rating Buy with a price target of $13.00
- On 11/8/2017 Citigroup Reiterated Rating add
- On 12/21/2017 Canaccord Genuity Set Price Target of rating Buy with a price target of $15.00
- On 4/10/2018 Stifel Nicolaus Downgraded rating Buy to Hold
- On 4/10/2018 Piper Jaffray Companies Downgraded rating Overweight to Neutral with a price target of $4.00
- On 4/10/2018 Seaport Global Securities Downgraded rating Buy to Neutral
- On 4/10/2018 Northland Securities Downgraded rating Outperform to Market Perform with a price target of $28.00
Recent Trading Activity for vTv Therapeutics Inc (NASDAQ:VTVT)
Shares of vTv Therapeutics Inc closed the previous trading session at with shares trading hands.